This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mikkel Pedersen, Ph.D.
CSO at Symphogen


Mikkel Wandahl Pedersen, is CSO at Symphogen a Servier Company. Mikkel has 15 years of experience in antibody discovery and development and contributed to the discovery and development of seven clinical stage antibody drug candidates within oncology and immuno-oncology. Mikkel has co-authored more than 40 peer-reviewed publications.

Agenda Sessions

  • Advantages and Challenges of Chicken-derived Therapeutic Antibodies

    On Demand
  • Antibody Screening, Discovery and Technology